Arkolith/Insider Trading/OCX/Form 4

Ross Douglas T.

Former CSO.Oncocyte Corp (OCX) · full profile →Form 4 · filed Dec 20, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
1 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 1, 2022Disposed to issuer(D)150K—$020K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 16, 2022Disposed to issuer(D)100K—$00
Dec 16, 2022Disposed to issuer(D)143K—$0112K
Dec 16, 2022Disposed to issuer(D)83K—$0167K
Dec 16, 2022Disposed to issuer(D)100K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-035991) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML